Capabilities | Work Together

The Board | Strategic Partners |  Scientific Advisors | University Collaboration

Prosonix is world leader in the commercialization of proprietary pharmaceutical ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions. A core expertise is the development of new ‘molecule to particle’ methods for manufacture of inhaled medicines.

We are based at the Oxford Science Park, which is approximately 4 miles south east of Oxford city centre. When travelling from the north use the M40 Junction 9, or from London use the M40 Junction 8, and head for the Oxford. Please see How to find us.

Our team of chemists and engineers work together in a unique multidisciplinary manner in order to solve our customers’ complex solid-state pharmaceutical problems. We leverage our proprietary intellectual property and patented bespoke sonoprocessing equipment to deliver long term and sustainable value.

Our core markets to date are pharmaceuticals, fine chemicals and minerals processing, where we employ our technology for the ‘Complete Crystallization Control’ of our customers’ products, processes and unit operations.

To complement our market led internal R & D programmes, we are actively engaged in several strategic partnerships with leading academic and technology institutions. These partnerships place us firmly at the cutting edge of the next generation of commercial scale ultrasonic assisted pharmaceutical particle engineering & process intensification solutions.

Please see Capabilities for a full explanation; but in brief, our technologies are useful for:

o Commercial scale cGMP Sonocrystallization with Prosonitron™ process and reactor technology

o Manufacture of inhaled medicine particles

o Control particle size, shape, crystallinity, polymorphism

o Improve batch consistency, filtration, isolation and drying

o Improve formulation consistency, stability and performance

o Enhance dissolution of poorly soluble drugs

o Replace problem physical seeding

o Eliminate micronization and milling

o Transform productivity and deliver return on investment

Prosonix technologies are proven across scale to give quantifiable productivity and performance enhancements in the primary and secondary manufacture of API’s, excipients and drug products.

See How we can work together. In summary, we will evaluate your problem by following a typical process flow including:

o Signing of a technical Non Disclosure Agreement

o Preparation of a fully costed proposal

o Carry out Proof of Concept/Process and/or pilot trials

Contact any one of the key contacts today for a solution to your particle engineering challenge.

Partner with Prosonix today!